Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint–Based Therapy in Patients With Advanced NSCLC
2021-04-15
0:00
15:06
Interview with Charu Aggarwal, MD, and Lova Sun, MD, authors of Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
Fler avsnitt från "JAMA Oncology Author Interviews"
Missa inte ett avsnitt av “JAMA Oncology Author Interviews” och prenumerera på det i GetPodcast-appen.